Nasdaq

Thermo Fisher (TMO) Launches New Chromosomal Microarray

Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...
technologynetworks

CollabRx, Affymetrix To Develop Analytical Tools For Integrated Clinical Cancer Panels

CollabRx, Inc. and Affymetrix, Inc. today announced an agreement to optimize the use of CollabRx's Genetic Variant Annotation (GVA) Service™ in connection with Affymetrix' OncoScan™ FFPE Assay Kit and ...
Labroots

Faster workflow and improved coverage for copy number analysis

Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The highly ...
Nature

Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability

The prevalence of developmental disabilities in the United States is reported to be 13.87% across all racial, ethnic, and socioeconomic groups. Microarrays have been recommended as first-tier tests ...
Nature

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of heterogeneous hematologic malignancies. This study aims to identify latent chromosomal abnormalities relevant to MDS, which may optimize the current ...